As airport workers face layoffs and furloughs due to the coronavirus, their co-workers from the Transportation Security Administration, who continue to receive paychecks, are stepping up to help.
In reopening plants, automakers face worker safety issues and must abide by local mandates, which Tesla CEO Elon Musk highlighted earlier this week. Then there are more complex problems.
The U.S. government last month sped $30 billion in stimulus payments to most healthcare providers that billed Medicare last year, but that speed resulted in taxpayers' money flowing to some companies and people facing civil or criminal fraud investigations, Reuters reports.
British aero-engine maker Rolls-Royce Holdings is considering cutting up to 15% of its workforce, a source told Reuters, as customers cut production and airlines park planes due to the coronavirus pandemic.
A liaison for a coalition of Target workers, Adam Ryan, said hourly employees have been put in an impossible position: Skip their paycheck or risk getting sick.
California Gov. Gavin Newsom said on Friday that the state is "days, not weeks" away from making significant modifications to its shelter-in-place order and could begin reopening parts of the country's largest state economy.
Trump walked back two statements about the U.S. response to coronavirus — one on testing and one on the use of disinfectants as treatment — in the past week alone.
Federal prosecutors this week informed GM that it is not currently a target in a yearslong investigation into corruption of the United Auto Workers union.
While the entire cruise industry has been rocked by the coronavirus pandemic, Carnival, which is the largest cruise company in the world, has been at the center of several high-profile outbreaks.
"There's all these downstream issues that really haven't been addressed yet," the Dallas Mavericks owner and "Shark Tank" investor told CNBC on Friday.
Trump's requirement that meatpacking plants stay open during the coronavirus pandemic raises questions about America's massive meat exports, especially to China.
Gilead Sciences is working to make remdesivir accessible and affordable, but it will eventually need to transition to a more "sustainable model," CEO Daniel O'Day says.